InvestorsHub Logo
Followers 85
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 264101

Friday, 05/13/2016 11:50:46 PM

Friday, May 13, 2016 11:50:46 PM

Post# of 346182
Robert Garnick with Stemcentrx and Peregrine Pharmaceuticals... and gets $10 Billion from Abbvie for Stemcentrx, how much for Peregrine Pharmaceuticals / PS Targeting / Avid ???

Those PPHM shares are worth more... much more, because Stemcentrx has much less than Peregrine (Venture Capital money though.... like that of Peter Thiel)

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News